0002141983 2026-09-10 2026-09-10 0002141983 ALLN:ClassBOrdinarySharesOrFounderSharesMember ALLN:ALLRSponsorLLCMember 2026-05-21 2026-05-21 0002141983 ALLN:ClassBOrdinarySharesToForfeitureMember ALLN:ALLRSponsorLLCMember 2026-05-21 2026-05-21 0002141983 ALLN:PrivateWarrantsMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 ALLN:OverAllotmentOptionMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 ALLN:PrivatePlacementMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionExercisedMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionNotExercisedMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ClassBOrdinarySharesMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 ALLN:PrivateWarrantsUnderwritersOverAllotmentOptionMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 ALLN:OfficeSpaceUtilitiesAndPersonnelMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 ALLN:OfferingRelatedAndOrganizationalExpensesMember ALLN:ALLRSponsorLLCOrItsAffiliatesMember 2026-09-10 2026-09-10 0002141983 ALLN:WorkingCapitalLoansMember ALLN:ALLRSponsorLLCOrItsAffiliatesMember 2026-09-10 2026-09-10 0002141983 spac:WarrantsMember ALLN:ALLRSponsorLLCOrItsAffiliatesMember 2026-09-10 2026-09-10 0002141983 ALLN:UnderwritersOverAllotmentOptionMember ALLN:ALLRSponsorLLCMember 2026-09-10 2026-09-10 0002141983 spac:FounderSharesMember 2026-09-10 2026-09-10 0002141983 ALLN:PrivateWarrantsMember 2026-09-10 2026-09-10 0002141983 ALLN:OrdinarySharesMember 2026-09-10 2026-09-10 0002141983 spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:UnderwritingDiscountsAndCommissionsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 spac:OverallotmentLiabilityMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:ProceedsHeldInTrustSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePublicWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesUnderlyingThePrivateWarrantsMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:AdditionalPrivateWarrantsSoldToSponsorMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:AdditionalPrivateWarrantsSoldToSponsorMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:AdditionalPrivateWarrantsSoldToSponsorMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:AdditionalPrivateWarrantsSoldToSponsorMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:AdditionalPrivateWarrantsSoldToSponsorMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:RepresentativeSharesMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:SharesSubjectToRedemptionMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionNotExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionNotExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionExercisedMember spac:NoRedemptionMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt25PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt50PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt75PercentOfMaximumMember 2026-05-31 2026-05-31 0002141983 ALLN:OrdinarySharesIncludedInTheUnitsOfferedMember spac:OverAllotmentOptionExercisedMember spac:RedemptionAt100PercentOfMaximumMember 2026-05-31 2026-05-31 iso4217:USD pure iso4217:USD shares shares false 0002141983 Sponsor Limited Liability Company S-1 Allarity Acquisition Corp. E9 Non-accelerated Filer true true false 3833333 500000 25000 0.0065 true true We will have P18M true true 1850000 1925000 1.00 1850000 1925000 true true <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td colspan="34" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">As of May 31, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Offering Price of $10.00 per Unit (No Redemption)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">25% of Maximum Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">50% of Maximum Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">75% of Maximum Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Maximum Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted NTBVPS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted NTBVPS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Difference between Adjusted NTBVPS and Offering Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted NTBVPS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Difference between Adjusted NTBVPS and Offering Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted NTBVPS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Difference between Adjusted NTBVPS and Offering Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Adjusted NTBVPS</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Difference between Adjusted NTBVPS and Offering Price</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="34" style="font-style: italic; text-align: center">Assuming Full Exercise of Over-Allotment Option</td><td style="font-style: italic"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_907_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zTEEZgSB69S9">7.29</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90C_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zB4qmKMb79Ck">6.69</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_903_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zMArBTCymtwc">3.31</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_906_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zEy8wGzPJ8P1">5.74</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_908_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_z6Hqi4XUuuEb">4.26</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90C_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zHyHfvHhnN3b">4.05</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_903_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zcslDnKhYfJb">5.95</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90A_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zfVeTCTgQr88">0.12</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 7%; text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90D_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zQd8jWswO752">9.88</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left"> </td><td colspan="32" style="font-style: italic; text-align: center">Assuming No Exercise of Over-Allotment Option</td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_906_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zFijAWpmTcVh">7.28</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_904_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_ze2pDEDqyWEf">6.68</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_903_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember_zOAmUN3ASbge">3.32</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90D_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zFwZ1av4gco3">5.73</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_909_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember_zb2kaJW7l1g7">4.27</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_901_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_zYVfacjW9fy8">4.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_900_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember_z412Vw93LuLa">5.97</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_909_espac--NetTangibleBookValueAdjustedPerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zRuZfn4oJ225">0.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGEpKDQpIEZvcmVwYXJ0LCBBZGp1c3RlZCBOVEJWAA__" id="xdx_90F_espac--DifferenceBetweenTheOfferingPriceAndTheAdjustedNetTangibleBookValue1PerShare_pid_c20260531__20260531__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember_zJxHQEvFEIic">9.91</td><td style="text-align: left"> </td></tr> </table> 10.00 7.29 6.69 3.31 5.74 4.26 4.05 5.95 0.12 9.88 7.28 6.68 3.32 5.73 4.27 4.03 5.97 0.09 9.91 Our sponsor, ALLR Sponsor LLC, is a Delaware <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_909_espac--SpacSponsorFormOfOrganization_dxL_c20260910__20260910_zMTjzWC8Xyla" title="::XDX::Limited%20Liability%20Company">limited liability company and a wholly owned subsidiary of Allarity Therapeutics, Inc. (“Allarity”). Allarity is a publicly traded precision medicine company. Our sponsor was formed for the sole purpose of holding securities of our company. ALLR Sponsor LLC Allarity Therapeutics, Inc. Sponsor Compensation The amount of compensation that may be received by our sponsor and its affiliates is summarized as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: left">Entity</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 44%">Amount of Compensation to be Received or Securities Issued or to be Issued</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 33%; text-align: justify">Consideration Paid or to be Paid</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ALLR Sponsor LLC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90F_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--ClassBOrdinarySharesMember_zhH49G4FaGjf">3,333,333 Class B ordinary shares, or <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_901_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--UnderwritersOverAllotmentOptionMember_zhfbw4WZRmx">3,833,333 Class B ordinary shares if the underwriters’ over-allotment option is exercised in full</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_909_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--ClassBOrdinarySharesMember_zOkTtppi30J9">25,000</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ALLR Sponsor LLC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_904_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsMember_zTPruJI3nV3h">1,850,000 private warrants, or <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90A_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsUnderwritersOverAllotmentOptionMember_zTQ7NMRsR8Kf">1,925,000 private warrants if the underwriters’ over-allotment option is exercised in full</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90F_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsMember_zeoSzoDw9S1k">1,850,000, or $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90C_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsUnderwritersOverAllotmentOptionMember_zZgsKvMLm2ad">1,925,000 if the underwriters’ over-allotment option is exercised in full</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ALLR Sponsor LLC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Upon the consummation of this offering, we will begin paying an amount equal to up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_906_espac--SponsorCompensationAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--OfficeSpaceUtilitiesAndPersonnelMember_zCiH86xWzuOj">20,000 per month, which will be paid upon the consummation of our initial business combination or at the time of our dissolution, assuming there is cash available. The $120,000 allocation in the Use of Proceeds table reflects six months of estimated payments; any additional amounts will be paid only from funds outside the trust account, loans or additional investments, or will be deferred and paid upon the consummation of our initial business combination or liquidation, assuming cash is available.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90C_espac--SponsorCompensationNature_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--OfficeSpaceUtilitiesAndPersonnelMember_zLmDHIJ45GL5">Office space, utilities and personnel</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ALLR Sponsor LLC, or its affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_903_espac--SponsorCompensationAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--OfferingRelatedAndOrganizationalExpensesMember_zRI3ml3vZeec">300,000</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_907_espac--SponsorCompensationNature_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--OfferingRelatedAndOrganizationalExpensesMember_zvSgPbHkYvR7">Repayment of loans anticipated to be made to us by our sponsor to cover offering-related and organizational expenses</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ALLR Sponsor LLC, or its affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Additional working capital loans, if any, up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_902_espac--SponsorCompensationAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--WorkingCapitalLoansMember_z53qr8ZzXPE1">1,500,000 of which may be converted into warrants at a price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90F_espac--PricePaidOrToBePaidForSecuritiesPerShare_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__spac--WarrantsMember_z13ad3BrPcn7">1.00 per warrant</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_90F_espac--SponsorCompensationNature_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--WorkingCapitalLoansMember_zVmQXP0ADhGg">Working capital loans to finance transaction costs in connection with an initial business combination</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">ALLR Sponsor LLC, or its affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Services in connection with identifying, investigating and completing an initial business combination</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Holders of Class B ordinary shares</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Subject to an anti-dilution adjustment, the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of all ordinary shares issued and outstanding upon completion of this initial public offering (excluding the representative shares) plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with or in relation to our initial business combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any private placement-equivalent warrants issued upon conversion of working capital loans; provided that the conversion will never occur on a less than one-for-one basis. The conversion ratio adjustment described above will not be reduced by any redemptions of Class A ordinary shares by public shareholders in connection with our initial business combination or any extension vote.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">N/A</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Independent Directors of Allarity Acquisition Corp.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Our independent directors will each receive an indirect interest in our founder shares through ownership interests in our sponsor, but Gerald W. McLaughlin, Jesper Hoiland and Joseph Renda will not have the right to participate in any decision regarding the disposal of any security held by the sponsor. It is expected that each of Mr. McLaughlin, Mr. Hoiland and Joseph Renda will be issued 20,000 shares in our sponsor upon joining our Board.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Service as an independent director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 19%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 44%">Our sponsor is currently a wholly owned subsidiary of Allarity and was formed solely to organize, sponsor, and manage our affairs. Our sponsor is expected to operate in a manner similar to a typical corporate subsidiary, with day-to-day oversight exercised by a limited number of officers and directors who are also officers, directors, or other representatives of Allarity. Major decisions relating to our sponsor, including matters involving us, capital commitments, governance, and strategic direction, are expected to be subject to oversight by Allarity’s senior management and, where appropriate, its board of directors. Accordingly, our sponsor’s management structure is integrated into Allarity’s broader corporate governance framework, with our sponsor ultimately reporting through Allarity’s executive management team and, indirectly, to the Allarity board of directors. Our sponsor does not have independent business operations separate from its role as our sponsor and is managed for the benefit of and under the control of its parent company, Allarity.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 33%"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 0.25in">(1) </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0.25pt">Amounts shown for founder shares and private warrants include the no-over-allotment and full-over-allotment cases, as applicable.</td></tr> </table> 3333333 3833333 25000 1850000 1925000 1850000 1925000 20000 Office space, utilities and personnel 300000 Repayment of loans anticipated to be made to us by our sponsor to cover offering-related and organizational expenses 1500000 1.00 Working capital loans to finance transaction costs in connection with an initial business combination <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0.25pt; width: 0.25in">(1) </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding: 0.25pt">Amounts shown for founder shares and private warrants include the no-over-allotment and full-over-allotment cases, as applicable.</td></tr> </table> In addition, because of the anti-dilution protection in the founder shares, any equity or equity-linked securities issued or deemed issued in connection with our initial business combination would be disproportionately dilutive to our Class A ordinary shares. <p id="xdx_896_espac--SpacSponsorAndAffiliatesInformationRestrictionsOnSaleOfSpacSecuritiesTableTextBlock_dU_zH3DHjXJJ90k" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Pursuant to a letter agreement to be entered into with us, each of our sponsor, directors and officers has agreed to restrictions on its ability to transfer, assign, or sell the founder shares and private warrants, as summarized in the table below. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: justify">Subject Securities</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 26%; text-align: justify">Expiration Date</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%">Natural Persons and Entities Subject to Restrictions</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%">Exceptions to Transfer Restrictions</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Founder Shares</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_90A_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260910__20260910__spac--SecurityClassAxis__spac--FounderSharesMember_zuwAAZUPBwV">The earlier of (A) six months after the completion of our initial business combination or earlier if, subsequent to our initial business combination, the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing 150 days after an initial business combination and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_908_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260910__20260910__spac--SecurityClassAxis__spac--FounderSharesMember_zOa8IUH4Of8k" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ALLR Sponsor LLC Thomas H. Jensen Jeffrey S. Ervin Gerald W. McLaughlin Jesper Hoiland Joseph Renda</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_907_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260910__20260910__spac--SecurityClassAxis__spac--FounderSharesMember_zrqNkcvToN53">Transfers permitted (a) to our or the Representative’s officers, directors, advisors or consultants, any affiliate or family member of any of our or the Representative’s officers, directors, advisors or consultants, any members or partners of the sponsor or the Representative or its respective affiliates and funds and accounts advised by such members or partners, any affiliates of the sponsor or the Representative, or any employees of such affiliates, (b) in the case of an individual, as a gift to such person’s immediate family or to a trust, the beneficiary of which is a member of such person’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such person; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement, in connection with an extension of the completion window or in connection with the consummation of a business combination at prices no greater than the price at which the shares or units were originally purchased; (f) pro rata distributions from our sponsor or the Representative to its respective members, partners or shareholders pursuant to our sponsor’s memorandum and articles of association, the Representative’s limited liability company agreement or other charter documents; (g) by virtue of the laws of the Cayman Islands and the amended and restated memorandum and articles of association upon dissolution of our sponsor or upon dissolution of the Representative, (h) in the event of our liquidation prior to our consummation of our initial business combination; (i) in the event that, subsequent to our consummation of an initial business combination, we complete a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; or (j) to a nominee or custodian of a person or entity to whom a transfer would be permissible under clauses (a) through (g); provided, however, that in the case of clauses (a) through (g) and clause (j) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: left">Private warrants (including the securities underlying such warrants)</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_907_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260910__20260910__spac--SecurityClassAxis__custom--PrivateWarrantsMember_zJmSXTVehYN1">After the completion of our initial business combination.</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_903_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260910__20260910__spac--SecurityClassAxis__custom--PrivateWarrantsMember_zHCoWOpFZwna">ALLR Sponsor LLC Thomas H. Jensen Jeffrey S. Ervin Gerald W. McLaughlin Jesper Hoiland Joseph Renda</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_904_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260910__20260910__spac--SecurityClassAxis__custom--PrivateWarrantsMember_zCF0SUmvBVdi">Same as above.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: left"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: left">Any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, any units, ordinary shares, founder shares or warrants</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_909_espac--SpacSponsorDescriptionOfExpirationDatesOfRestrictionsTextBlock_c20260910__20260910__spac--SecurityClassAxis__custom--OrdinarySharesMember_zeEkL7aAZZ7e">180 days after the date of this prospectus.</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_900_espac--SpacSponsorPersonsAndEntitiesSubjectToRestrictions_c20260910__20260910__spac--SecurityClassAxis__custom--OrdinarySharesMember_zr07L2negCmc">ALLR Sponsor LLC Thomas H. Jensen Jeffrey S. Ervin Gerald W. McLaughlin Jesper Hoiland Joseph Renda</td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.25pt; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.25pt; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpKDkpIFJlc3RyaWN0aW9ucyBvbiBTZWxsaW5nIFNlY3VyaXRpZXMA" id="xdx_908_espac--SpacSponsorDescriptionOfExceptionsToRestrictionsTextBlock_c20260910__20260910__spac--SecurityClassAxis__custom--OrdinarySharesMember_zzQFTAp2WE3k">We, our sponsor and our directors and officers have agreed that we and they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, without the prior written consent of Maxim for a period of 180 days after the date of this prospectus, any units, warrants, ordinary shares or any other securities convertible into, exercisable for or exchangeable for ordinary shares, subject to certain customary exceptions. However, the foregoing shall not apply to the forfeiture of any founder shares pursuant to their terms or any transfer of founder shares to any current or future independent director of the company (as long as such current or future independent director transferee is subject to the letter agreement, filed herewith, or executes an agreement substantially identical to the letter agreement, as applicable to directors and officers at the time of such transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result of such transfer, any related Section 16 filing includes a practical explanation as to the nature of the transfer). Maxim in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice.</td></tr> </table> The earlier of (A) six months after the completion of our initial business combination or earlier if, subsequent to our initial business combination, the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing 150 days after an initial business combination and (B) the date following the completion of our initial business combination on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. ALLR Sponsor LLC Thomas H. Jensen Jeffrey S. Ervin Gerald W. McLaughlin Jesper Hoiland Transfers permitted (a) to our or the Representative’s officers, directors, advisors or consultants, any affiliate or family member of any of our or the Representative’s officers, directors, advisors or consultants, any members or partners of the sponsor or the Representative or its respective affiliates and funds and accounts advised by such members or partners, any affiliates of the sponsor or the Representative, or any employees of such affiliates, (b) in the case of an individual, as a gift to such person’s immediate family or to a trust, the beneficiary of which is a member of such person’s immediate family, an affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of such person; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with any forward purchase agreement or similar arrangement, in connection with an extension of the completion window or in connection with the consummation of a business combination at prices no greater than the price at which the shares or units were originally purchased; (f) pro rata distributions from our sponsor or the Representative to its respective members, partners or shareholders pursuant to our sponsor’s memorandum and articles of association, the Representative’s limited liability company agreement or other charter documents; (g) by virtue of the laws of the Cayman Islands and the amended and restated memorandum and articles of association upon dissolution of our sponsor or upon dissolution of the Representative, (h) in the event of our liquidation prior to our consummation of our initial business combination; (i) in the event that, subsequent to our consummation of an initial business combination, we complete a liquidation, merger, share exchange or other similar transaction which results in all of our shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; or (j) to a nominee or custodian of a person or entity to whom a transfer would be permissible under clauses (a) through (g); provided, however, that in the case of clauses (a) through (g) and clause (j) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. After the completion of our initial business combination. ALLR Sponsor LLC Thomas H. Jensen Jeffrey S. Ervin Gerald W. McLaughlin Jesper Hoiland Same as above. 180 days after the date of this prospectus. ALLR Sponsor LLC Thomas H. Jensen Jeffrey S. Ervin Gerald W. McLaughlin Jesper Hoiland We, our sponsor and our directors and officers have agreed that we and they will not offer, sell, contract to sell, pledge or otherwise dispose of, directly or indirectly, without the prior written consent of Maxim for a period of 180 days after the date of this prospectus, any units, warrants, ordinary shares or any other securities convertible into, exercisable for or exchangeable for ordinary shares, subject to certain customary exceptions. However, the foregoing shall not apply to the forfeiture of any founder shares pursuant to their terms or any transfer of founder shares to any current or future independent director of the company (as long as such current or future independent director transferee is subject to the letter agreement, filed herewith, or executes an agreement substantially identical to the letter agreement, as applicable to directors and officers at the time of such transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result of such transfer, any related Section 16 filing includes a practical explanation as to the nature of the transfer). Maxim in its sole discretion may release any of the securities subject to these lock-up agreements at any time without notice. 10,000,000 units, at $10.00 per unit, each unit consisting of:one Class A ordinary share; andone-half of one redeemable warrant. Nasdaq rules provide that at least <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyLCBTUEFDIFJlZ2lzdGVyZWQgT2ZmZXJpbmdzAA__" id="xdx_902_espac--SpacTrustOrEscrowAccountGrossOfferingProceedsPlacedPercent_dp_uPure_c20260910__20260910_z8SwUkjvxbKf">90% of the gross proceeds from this offering be deposited in a trust account. Of the net proceeds we receive from this offering, $100,000,000, or $10.00 per unit ($115,000,000, or $10.00 per unit, if the underwriters’ over-allotment option is exercised in full) will be deposited into a trust account in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and approximately $500,000 will be available outside the trust account for working capital following the closing of this offering.The funds in the trust account will be invested only in specified U.S. government treasury bills or in specified money market funds. Except with respect to interest earned on the funds held in the trust account that may be released to us to pay our taxes, if any, the proceeds from this offering held in the trust account will not be released from the trust account until the earliest of (a) the completion of our initial business combination, or (b) the redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association to (i) modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within the completion window; or (ii) with respect to any other provision relating to shareholders’ rights or pre-business combination activity and (iii) the redemption of all of our public shares if we are unable to complete our initial business combination within the completion window, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of our creditors, if any, which could have priority over the claims of our public shareholders. Public shareholders who redeem their Class A ordinary shares in connection with a shareholder vote described in clause (b) in the preceding sentence shall not be entitled to funds from the trust account upon the subsequent completion of an initial business combination or liquidation if we are unable to complete an initial business combination within the completion window with respect to such Class A ordinary shares so redeemed. 0.90 100000000 We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account as of two business days prior to the consummation of our initial business combination, including interest earned on the funds held in the trust account and not previously released to us to pay our franchise and income taxes, divided by the number of then outstanding public shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be $10.00 per public share. The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by underwriting compensation payable outside the trust account. There will be no redemption rights upon the completion of our initial business combination with respect to our warrants.Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any founder shares held by them and any public shares they may acquire during or after this offering in connection with the completion of our initial business combination or otherwise.We may require our public shareholders seeking to exercise their redemption rights, whether they are record holders or hold their shares in “street name,” to either tender their certificates to our transfer agent prior to the date set forth in the tender offer documents or proxy materials mailed to such holders, or up to two business days prior to the vote on the proposal to approve the initial business combination in the event we distribute proxy materials, or to deliver their shares to the transfer agent electronically using the Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, at the holder’s option. The tender offer or proxy materials, as applicable, that we will furnish to holders of our public shares in connection with our initial business combination will indicate whether we are requiring public shareholders to satisfy such delivery requirements. Each of our directors and officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity. Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity, and only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association will provide that, subject to his or her fiduciary duties under Cayman Islands law, no director or officer shall be disqualified or prevented from contracting with the company nor shall any contract or transaction entered into by or on behalf of the company in which any director shall have an interest be liable to be avoided provided that the director provides full and frank disclosure of the nature of the interest prior to its approval. A director shall be at liberty to vote in respect of any contract or transaction in which he or she is interested provided that the nature of such interest shall be disclosed at or prior to its consideration or any vote thereon by the board of directors. We do not believe, however, that any fiduciary duties or contractual obligations of our directors or officers would materially undermine our ability to complete our business combination.Also, none of Allarity, our sponsor or any of our directors and officers is prohibited from sponsoring, investing or otherwise becoming involved with, any other blank check companies, including in connection with their initial business combinations.Additionally, none of Allarity, our sponsor or any other entity currently has any obligation or duty to provide us with any potential business combination opportunity. <p id="xdx_89A_espac--SpacAdjustedNetTangibleBookValuePerShareWithSourcesOfDilutionTableTextBlock_dU_gL3SANTBVPSWS-QSLORPT_zn8HDsssr6ke" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> The following tables illustrate the dilution to the public shareholders on a per-share basis, assuming no value is attributed to the warrants included in the units or the private warrants: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">No exercise of over-allotment option</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260531__20260531__spac--RedemptionLevelAxis__spac--NoRedemptionMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zVCrOa0ytnT3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zNpNS8qFUST3" style="border-bottom: Black 1pt solid; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zPEMYrp4x66k" style="border-bottom: Black 1pt solid; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_z8Uf4xmC1RW5" style="border-bottom: Black 1pt solid; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zLtPBa934AQ7" style="border-bottom: Black 1pt solid; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_espac--RegisteredOfferingPrice1PerShare_pid_zJiENM8IBNwg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Public offering price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_espac--NetTangibleBookValuePreTransactionPerShare_pid_zJlEVIZRLN4c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net tangible book value before this offering and excluding deferred offering costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_espac--NetTangibleBookValueIncreaseFromPublicShareholdersPerShare_pid_zMvPObXgnEo" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Increase attributable to public shareholders and sale of the private warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.31</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.71</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.76</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.06</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.12</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_espac--NetTangibleBookValueAdjustedPerShare_pid_zrox1HNUmoZ2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Pro forma net tangible book value after this offering</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.28</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.68</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.73</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.03</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.09</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_espac--NetTangibleBookValueAmountOfDilutionPerShare_pid_zvS0RV6ncpr6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.72</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.32</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4.27</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.97</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.91</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Percentage of dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.20</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">33.20</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">42.70</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">59.70</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">99.10</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Full exercise of over-allotment option</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260531__20260531__spac--RedemptionLevelAxis__spac--NoRedemptionMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zXzde7S9X0B8" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_499_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_z5oq4OgL229a" style="border-bottom: Black 1pt solid; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_496_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zfNhSJYaFcf4" style="border-bottom: Black 1pt solid; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zdq1OaLaMwTf" style="border-bottom: Black 1pt solid; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49A_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zUNbSKGW51y" style="border-bottom: Black 1pt solid; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_404_espac--RegisteredOfferingPrice1PerShare_pid_zlwp8pMHFPWi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%">Public offering price</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10.00</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_espac--NetTangibleBookValuePreTransactionPerShare_pid_zD38EgLfAqOl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net tangible book value before this offering and excluding deferred offering costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_espac--NetTangibleBookValueIncreaseFromPublicShareholdersPerShare_pid_zSmNj3faJ7ue" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Increase attributable to public shareholders and sale of the private warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.32</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.72</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.77</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.08</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.15</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_402_espac--NetTangibleBookValueAdjustedPerShare_pid_zank06fjdzL9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Pro forma net tangible book value after this offering</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">7.29</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">6.69</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">5.74</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">4.05</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">0.12</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_espac--NetTangibleBookValueAmountOfDilutionPerShare_pid_zbwM0q0X2x68" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2.71</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">3.31</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4.26</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5.95</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">9.88</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Percentage of dilution to public shareholders</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27.10</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">33.10</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">42.60</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">59.50</td><td style="padding-bottom: 2.5pt; text-align: left">%</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">98.80</td><td style="padding-bottom: 2.5pt; text-align: left">%</td></tr> </table> <div>The pro forma net tangible book value per share after the offering is calculated as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">No exercise of over-allotment option</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20260531__20260531__spac--RedemptionLevelAxis__spac--NoRedemptionMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_z9ORZh00kFBb" style="border-bottom: Black 1pt solid; text-align: center">No Redemption</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zr6lUjEIHPo4" style="border-bottom: Black 1pt solid; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49B_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zNCkoQzXhPr9" style="border-bottom: Black 1pt solid; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_494_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zDFikFFux8oc" style="border-bottom: Black 1pt solid; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionNotExercisedMember_zfbVkFMSOQyf" style="border-bottom: Black 1pt solid; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_espac--NetTangibleBookValue_hspac--DilutionSourceAxis__custom--NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember_zdlUKgmPDwO" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Net tangible book deficit before this offering and excluding deferred offering costs</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(112,519</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(112,519</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(112,519</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(112,519</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(112,519</td><td style="text-align: left">)</td></tr> <tr id="xdx_40F_espac--NetTangibleBookValueProceedsFromOffering_hspac--DilutionSourceAxis__custom--NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember_zytr1eUvoG1b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Net proceeds from this offering and sale of the private warrants, net of expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">100,500,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember_zgVUqauIdCKk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Plus: Offering costs paid in advance, excluded from tangible book value</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137,519</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137,519</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137,519</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137,519</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">137,519</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--UnderwritingDiscountsAndCommissionsMember_z6qSjcAArcm4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Underwriting discounts and commissions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__spac--OverallotmentLiabilityMember_z0ND0cjRpCXa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Over-allotment liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(181,350</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(181,350</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(181,350</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(181,350</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(181,350</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_403_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--ProceedsHeldInTrustSubjectToRedemptionMember_zbrnhlZK98ie" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Proceeds held in trust subject to redemption(2)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(25,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(50,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(75,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(100,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40B_espac--NetTangibleBookValueAdjusted_zkQnDwXt6jid" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2pt"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">100,343,650</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">75,343,650</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">50,343,650</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">25,343,650</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">343,650</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember_zgRtUDvgdQ6c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares issued and outstanding prior to this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember_zn80e1bwQ5jb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares forfeited if over-allotment is not exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(500,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(500,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_402_espac--NumberOfSharesUsedOffering_hspac--DilutionSourceAxis__custom--OrdinarySharesIncludedInTheUnitsOfferedMember_z4CQe3uiCZy2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares included in the units offered</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesUnderlyingThePublicWarrantsMember_zVtetbph1rGf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares underlying the public warrants (excluded from calculation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesUnderlyingThePrivateWarrantsMember_zdJyj4iAl4gf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares underlying the private warrants (excluded from calculation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--RepresentativeSharesMember_zgeDNk7N862" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Representative Shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">450,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--SharesSubjectToRedemptionMember_zl2SKTYy5vbg" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Shares subject to redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(7,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40A_espac--NumberOfSharesUsedAdjustment_z1ObszXGDn36" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2pt"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">13,783,333</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">11,283,333</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">8,783,333</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">6,283,333</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">3,783,333</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Full exercise of over-allotment option</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260531__20260531__spac--RedemptionLevelAxis__spac--NoRedemptionMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zlgoS2aY4By3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">No Redemption</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_492_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt25PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_z7DuGksRtAEj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">25% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt50PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zqmcQ3KdaiSl" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">50% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49C_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt75PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zPpQXIJgDhO6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">75% of Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49D_20260531__20260531__spac--RedemptionLevelAxis__spac--RedemptionAt100PercentOfMaximumMember__spac--OverAllotmentOptionAxis__spac--OverAllotmentOptionExercisedMember_zjSJVYk7qwf3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Maximum Redemptions</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Numerator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_espac--NetTangibleBookValue_hspac--DilutionSourceAxis__custom--NetTangibleBookDeficitBeforeThisOfferingAndExcludingDeferredOfferingCostsMember_zbnx0fWdCgul" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; text-align: left; padding-bottom: 1pt">Net tangible book deficit before this offering and excluding deferred offering costs</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(112,519</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(112,519</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(112,519</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(112,519</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 9%; text-align: right">(112,519</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_40F_espac--NetTangibleBookValueProceedsFromOffering_hspac--DilutionSourceAxis__custom--NetProceedsFromThisOfferingAndSaleOfThePrivateWarrantsNetOfExpensesMember_ztGX7DQpaZni" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Net proceeds from this offering and sale of the private warrants, net of expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">115,500,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--OfferingCostsPaidInAdvanceExcludedFromTangibleBookValueMember_zluB763l2G32" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Plus: Offering costs paid in advance, excluded from tangible book value</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137,519</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137,519</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137,519</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137,519</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">137,519</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--UnderwritingDiscountsAndCommissionsMember_zXiAUdRWN74d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Underwriting discounts and commissions</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__spac--OverallotmentLiabilityMember_zoUSdHsZodjk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: Over-allotment liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_espac--NetTangibleBookValueAdjusted_hspac--DilutionSourceAxis__custom--ProceedsHeldInTrustSubjectToRedemptionMember_zRStskcVickk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Proceeds held in trust subject to redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(28,750,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(57,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(86,250,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(115,000,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_400_espac--NetTangibleBookValueAdjusted_zOxro98uaq44" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2pt"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">115,525,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">86,775,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">58,025,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">29,275,000</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left">$</td><td style="border-bottom: Black 2pt double; text-align: right">525,000</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Denominator:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesIssuedAndOutstandingPriorToThisOfferingMember_zQwiiDZwgT2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares issued and outstanding prior to this offering</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,833,333</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesForfeitedIfOverAllotmentIsNotExercisedMember_zFJPdi1Kl1g5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares forfeited if over-allotment is not exercised</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_espac--NumberOfSharesUsedOffering_hspac--DilutionSourceAxis__custom--OrdinarySharesIncludedInTheUnitsOfferedMember_zClFqpz8zMu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares included in the units offered</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">11,500,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesUnderlyingThePublicWarrantsMember_zOi1nfpFRfu6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ordinary shares underlying the public warrants (excluded from calculation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--OrdinarySharesUnderlyingThePrivateWarrantsMember_zVFtbJ8DpBJk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Ordinary shares underlying the private warrants (excluded from calculation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--AdditionalPrivateWarrantsSoldToSponsorMember_ziaDVLkL3C73" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additional private warrants sold to sponsor (excluded from calculation)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--RepresentativeSharesMember_z0z07Cn7yNEb" style="vertical-align: bottom; background-color: White"> <td>Representative Shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">517,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">517,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">517,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">517,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">517,500</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_espac--NumberOfSharesUsedAdjustment_hspac--DilutionSourceAxis__custom--SharesSubjectToRedemptionMember_zA7azY4tyEr9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less: Shares subject to redemption</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,875,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(5,750,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(8,625,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(11,500,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_408_espac--NumberOfSharesUsedAdjustment_zvO1goU216Gh" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2pt"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">15,850,833</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">12,975,833</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">10,100,833</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">7,225,833</td><td style="padding-bottom: 2pt; text-align: left"> </td><td style="padding-bottom: 2pt"> </td> <td style="border-bottom: Black 2pt double; text-align: left"> </td><td style="border-bottom: Black 2pt double; text-align: right">4,350,833</td><td style="padding-bottom: 2pt; text-align: left"> </td></tr> </table> </div> 10.00 10.00 10.00 10.00 10.00 -0.03 -0.03 -0.03 -0.03 -0.03 7.31 6.71 5.76 4.06 0.12 7.28 6.68 5.73 4.03 0.09 2.72 3.32 4.27 5.97 9.91 10.00 10.00 10.00 10.00 10.00 -0.03 -0.03 -0.03 -0.03 -0.03 7.32 6.72 5.77 4.08 0.15 7.29 6.69 5.74 4.05 0.12 2.71 3.31 4.26 5.95 9.88 -112519 -112519 -112519 -112519 -112519 100500000 100500000 100500000 100500000 100500000 137519 137519 137519 137519 137519 -181350 -181350 -181350 -181350 -181350 -25000000 -50000000 -75000000 -100000000 100343650 75343650 50343650 25343650 343650 3833333 3833333 3833333 3833333 3833333 -500000 -500000 -500000 -500000 -500000 10000000 10000000 10000000 10000000 10000000 450000 450000 450000 450000 450000 -2500000 -5000000 -7500000 -10000000 13783333 11283333 8783333 6283333 3783333 -112519 -112519 -112519 -112519 -112519 115500000 115500000 115500000 115500000 115500000 137519 137519 137519 137519 137519 -28750000 -57500000 -86250000 -115000000 115525000 86775000 58025000 29275000 525000 3833333 3833333 3833333 3833333 3833333 11500000 11500000 11500000 11500000 11500000 517500 517500 517500 517500 517500 -2875000 -5750000 -8625000 -11500000 15850833 12975833 10100833 7225833 4350833 We may need to obtain additional financing either to complete an initial business combination or because we become obligated to redeem a significant number of our public shares upon completion of an initial business combination. We intend to acquire a business with an enterprise value significantly above the net proceeds of this offering and the sale of the private warrants. Depending on the size of the transaction or the number of public shares we become obligated to redeem, we may potentially utilize several additional financing sources, including but not limited to the issuance of additional securities to the sellers of a target business, debt issued by banks or other lenders or the owners of the target, a private placement to raise additional funds, or a combination of the foregoing. Any issuances of equity securities in connection with any additional financing transactions could dilute the interests of our existing shareholders. Such financing transactions may be significantly dilutive to the post-combination company, and represent the type of financing risk that is not associated with traditional initial public offerings. Any financing transaction with the entities in which related parties hold ownership interests present potential for conflicts of interest, as the interests of these entities and their equity holders may not align with the interests of our company and our unaffiliated shareholders with respect to the negotiation of, and certain other matters related to, financing transactions with such entities. To the extent that additional financing proves to be unavailable when needed to complete our initial business combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative target business candidate. If we are unable to complete an initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the trust account. In addition, following an initial business combination, if cash on hand is insufficient to meet our obligations or our working capital needs, we may need to obtain additional financing. Sponsor Compensation The amount of compensation that may be received by our sponsor and its affiliates is summarized as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: justify">Entity</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 42%">Amount of Compensation to be Received or Securities Issued or to be Issued</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: justify"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: justify">Consideration Paid or to be Paid</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">ALLR Sponsor LLC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_90D_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--ClassBOrdinarySharesMember_zm0g5gMFX9Gk">3,333,333 Class B ordinary shares, or <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAyKGIpKDYpIFByb3NwZWN0dXMgU3VtbWFyeSwgU3BvbnNvciBDb21wZW5zYXRpb24A" id="xdx_903_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--UnderwritersOverAllotmentOptionMember_z6yyA599YPdb">3,833,333 Class B ordinary shares if the underwriters’ over-allotment option is exercised in full</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_90E_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--ClassBOrdinarySharesMember_zPIxx18X6t2e">25,000</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">ALLR Sponsor LLC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_905_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsMember_zhAWd8cT54cc">1,850,000 private warrants, or <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_907_espac--SecuritiesIssuedOrToBeIssuedShares_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsUnderwritersOverAllotmentOptionMember_zOyscN4T9zng">1,925,000 private warrants if the underwriters’ over-allotment option is exercised in full</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">$<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_90A_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsMember_zwgSzYUTRhfe">1,850,000, or $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_90E_espac--PricePaidOrToBePaidForSecuritiesTotalAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--PrivateWarrantsUnderwritersOverAllotmentOptionMember_zZ4HzIC8FM37">1,925,000 if the underwriters’ over-allotment option is exercised in full</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">ALLR Sponsor LLC</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Upon the consummation of this offering, we will begin paying an amount equal to up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_909_espac--SponsorCompensationAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--OfficeSpaceUtilitiesAndPersonnelMember_zbbxXuvlMts4">20,000 per month, which will be paid upon the consummation of our initial business combination or at the time of our dissolution, assuming there is cash available. The $120,000 allocation in the Use of Proceeds table reflects six months of estimated payments; any additional amounts will be paid only from funds outside the trust account, loans or additional investments, or will be deferred and paid upon the consummation of our initial business combination or liquidation, assuming cash is available.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_909_espac--SponsorCompensationNature_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCMember__spac--CompensationNatureAxis__custom--OfficeSpaceUtilitiesAndPersonnelMember_zepHgZuzvxcg">Office space, utilities and personnel</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">ALLR Sponsor LLC, or its affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_905_espac--SponsorCompensationAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--OfferingRelatedAndOrganizationalExpensesMember_zsk7bQq9Gfcd">300,000</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_909_espac--SponsorCompensationNature_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--OfferingRelatedAndOrganizationalExpensesMember_zWxVk7FwFpy4">Repayment of loans anticipated to be made to us by our sponsor to cover offering-related and organizational expenses</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">ALLR Sponsor LLC, or its affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Additional working capital loans, if any, up to $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_90C_espac--SponsorCompensationAmount_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--WorkingCapitalLoansMember_z92iFVUeSVj5">1,500,000 of which may be converted into warrants at a price of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_909_espac--PricePaidOrToBePaidForSecuritiesPerShare_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__spac--WarrantsMember_z9bRSorXfkv1">1.00 per warrant</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFMtSyAxNjAzKGEpIFNQQUMgU3BvbnNvcgA_" id="xdx_903_espac--SponsorCompensationNature_c20260910__20260910__spac--SpacSponsorAffiliateOrPromoterAxis__custom--ALLRSponsorLLCOrItsAffiliatesMember__spac--CompensationNatureAxis__custom--WorkingCapitalLoansMember_zJKBpcaKTRv3">Working capital loans to finance transaction costs in connection with an initial business combination</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">ALLR Sponsor LLC, or its affiliates</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Reimbursement for any out-of-pocket expenses related to identifying, investigating and completing an initial business combination</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Services in connection with identifying, investigating and completing an initial business combination</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Holders of Class B ordinary shares</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Subject to an anti-dilution adjustment, the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, on an as-converted basis, 25% of the sum of all ordinary shares issued and outstanding upon completion of this initial public offering (excluding the representative shares) plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with or in relation to our initial business combination, excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial business combination and any private placement-equivalent warrants issued upon conversion of working capital loans; provided that the conversion will never occur on a less than one-for-one basis. The conversion ratio adjustment described above will not be reduced by any redemptions of Class A ordinary shares by public shareholders in connection with our initial business combination or any extension vote.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">N/A</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Independent Directors of Allarity Acquisition Corp.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif">Our independent directors will each receive an indirect interest in our founder shares through ownership interests in our sponsor, but Gerald W. McLaughlin, Jesper Hoiland and Joseph Renda will not have the right to participate in any decision regarding the disposal of any security held by the sponsor, or otherwise, as any such decisions would be made by the sponsor’s board as a collective body It is expected that each of Mr. McLaughlin, Mr. Hoiland and Joseph Renda be issued 20,000 shares in our sponsor upon joining our Board.</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Service as an independent director</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0.2pt; width: 0.25in; text-align: justify">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; padding: 0.2pt; text-align: justify">Amounts shown for founder shares and private warrants include the no-over-allotment and full-over-allotment cases, as applicable.</td></tr> </table> 3333333 3833333 25000 1850000 1925000 1850000 1925000 20000 Office space, utilities and personnel 300000 Repayment of loans anticipated to be made to us by our sponsor to cover offering-related and organizational expenses 1500000 1.00 Working capital loans to finance transaction costs in connection with an initial business combination P18M We may also hold a <span id="xdx_904_espac--DeSpacConsummationTimeframeExtensionSecurityHoldersVotingOrRedemptionRightsFlag_dbT_c20260910__20260910_z7aLzsPuxWef" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shareholder vote at any time to amend our amended and restated memorandum and articles of association to modify the amount of time we will have to consummate an initial business combination (as well as to modify the substance or timing of our obligation to redeem 100% of our public shares if we have not consummated an initial business combination within the time periods described herein or with respect to any other provisions relating to shareholders’ rights or pre-initial business combination activity). true true P18M true There is no limit on the number of extensions that we may seek. If we do not or are unable to extend the time period to consummate our initial business combination, our sponsor’s investment in our founder shares and our private warrants will be worthless. If we do not complete our initial business combination within the completion window and do not hold a shareholder vote to amend our amended and restated memorandum and articles of association to extend the amount of time we will have to consummate an initial business combination, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest earned on the funds held in the trust account (less taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject, in each case, to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There is no limitation on our ability to raise funds privately or through loans in connection with our initial business combination. <p id="xdx_897_espac--SpacSponsorAgreementArrangementOrUnderstandingOnTheRedemptionOfOutstandingSecuritiesTextBlock_dU_zJNqtXVNz6t1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Redemption of public shares and liquidation if no initial business combination Our initial shareholders, officers and directors have agreed that we will have until 18 months from the closing of this offering to consummate our initial business combination. If we are unable to complete our initial business combination within the completion window, we will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less up to $100,000 of interest to pay dissolution expenses (which interest shall be net of taxes payable) divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject in each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless if we fail to complete our initial business combination within the 18-month time period. Our initial shareholders, officers and directors have entered into a letter agreement with us, pursuant to which they have waived their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination within the completion window. However, if our initial shareholders acquire public shares after this offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial business combination within the completion window. Our initial shareholders, officers and directors have agreed, pursuant to a written letter agreement with us, that they will not propose any amendment to our amended and restated memorandum and articles of association (i) that would modify the substance or timing of our obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within the completion window or (ii) with respect to the other provisions relating to shareholders’ rights or pre-initial business combination activity, unless we provide our public shareholders with the opportunity to redeem their Class A ordinary shares upon approval of any such amendment at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable) divided by the number of then outstanding public shares. <p id="xdx_89B_espac--SpacOfficersAndDirectorsFiduciaryDutiesToOtherCompaniesDescriptionTextBlock_dU_z4m9Yi4aXRV1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> Conflicts of Interest Under Cayman Islands law, directors and officers owe the following fiduciary duties: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">directors should not improperly fetter the exercise of future discretion;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">duty to exercise independent judgment.</td></tr> </table> In addition to the above, directors also owe a duty of care which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge skill and experience which that director has. As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings. Each of our directors and officers presently has, and in the future any of our directors and our officers may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity. Accordingly, subject to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an acquisition opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will need to honor his or her fiduciary or contractual obligations to present such acquisition opportunity to such entity, and only present it to us if such entity rejects the opportunity. Our amended and restated memorandum and articles of association will provide that, subject to his or her fiduciary duties under Cayman Islands law, no director or officer shall be disqualified or prevented from contracting with the company nor shall any contract or transaction entered into by or on behalf of the company in which any director shall have an interest be liable to be avoided provided that the director provides full and frank disclosure of the nature of the interest prior to its approval. A director shall be at liberty to vote in respect of any contract or transaction in which he or she is interested provided that the nature of such interest shall be disclosed at or prior to its consideration or any vote thereon by the board of directors. We do not believe, however, that any fiduciary duties or contractual obligations of our directors or officers would materially undermine our ability to complete our business combination. Potential investors should also be aware of the following other potential conflicts of interest: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.5in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif">In the course of their other business activities, our officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Our initial shareholders will agree to waive their redemption rights with respect to their founder shares and any public shares held by them in connection with the completion of our initial business combination. Our directors and officers have also entered into the letter agreement, imposing similar obligations on them with respect to public shares acquired by them, if any. Additionally, our initial shareholders will agree to waive their redemption rights with respect to their founder shares if we fail to consummate our initial business combination within the completion window. However, if our initial shareholders or any of our officers, directors or affiliates acquire public shares in or after this offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to consummate our initial business combination within the completion window. If we do not complete our initial business combination within such applicable time period, the private warrants will expire worthless; no proceeds from the sale of the private warrants will be deposited in the trust account or used to fund redemption of our public shares. With certain limited exceptions, the founder shares and private warrants will be subject to the following transfer restrictions: 100% of the founder shares will not be transferable, assignable or salable by our initial shareholders, and will remain in escrow, until the earlier of (i) twelve months after the date of the consummation of our initial business combination and (ii) the date on which we consummate a liquidation, merger, amalgamation, share exchange, reorganization, or other similar transaction after our initial business combination that results in all of our shareholders having the right to exchange their ordinary shares for cash, securities or other property. With certain limited exceptions, the private warrants and underlying securities will not be transferable, assignable or salable by our sponsor until 30 days after the completion of our initial business combination. Since our sponsor and officers and directors may directly or indirectly own ordinary shares and warrants following this offering, our officers and directors may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business combination.</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.5in; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif">Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included by a target business as a condition to any agreement with respect to our initial business combination.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Our sponsor, officers or directors may have a conflict of interest with respect to evaluating a business combination and financing arrangements as we may obtain loans from our sponsor or an affiliate of our sponsor or any of our officers or directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such working capital loans may be convertible into private placement-equivalent warrants at a price of $1.00 per warrant (which, for example, would result in the holders being issued 1,500,000 warrants if $1,500,000 of notes were so converted), at the option of the lender. Such warrants would be identical to the private warrants, including as to exercise price, exercisability and exercise period.</td></tr> </table> The conflicts described above may not be resolved in our favor. Accordingly, as a result of multiple business affiliations, our officers and directors may have similar legal obligations relating to presenting business opportunities meeting the above-listed criteria to multiple entities. Below is a table summarizing the entities to which our officers and directors currently have fiduciary duties or contractual obligations: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%">Individual(1)(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center">Entity</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: center">Entity’s Business</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center">Affiliation</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Thomas H. Jensen</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Allarity Therapeutics, Inc.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">CEO & Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Valion Bio, Inc.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Jeffrey S. Ervin</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Allarity Therapeutics, Inc.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Chief Financial Officer</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%">Gerald W. McLaughlin</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%">Allarity Therapeutics, Inc.</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 28%">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%">Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">Life Biosciences, Inc.</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">CEO & Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Jesper Hoiland</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Allarity Therapeutics, Inc.</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Flen Health SA</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Director</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">SciBase Holding AB</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Biotech</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Chairman</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Joseph Renda</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Amneal Pharmaceuticals</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">A pharmaceutical company</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Senior Vice President and Chief Commercial Officer</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">(1)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Each of the entities listed in this table has priority and preference relative to our company with respect to the performance by each individual listed in this table of his obligations and the presentation by each such individual of business opportunities.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">(2)</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Each individual listed has a fiduciary duty with respect to each of the listed entities opposite from his name.</td></tr> </table>